Simple Non-Invasive Test Predicts Heart Risk in Postmenopausal Women

Endothelial Dysfunction is a Disordered Function of Very Small
Coronary Vessels That Cannot Be Seen During Cardiac Catheterization
and Contributes Significant to Predicting Heart Risk in
Post-Menopausal Women
PITTSBURGH--(Business Wire)--
Endothelial dysfunction is a disordered function of very small
coronary vessels that cannot be seen by angiograms done during cardiac
catheterization. The impairment of endothelial function is the primary
etiology implicated in the origin and development of atherosclerosis.
In a prospective study of 2264 post-menopausal women, endothelial
function was measured by utilizing the noninvasive measurement of the
brachial artery flow characteristics. When added to age and other
conventional cardiovascular risk factors (smoking habits, presence of
hypercholesterolemia, history of diabetes, hypertension), endothelial
dysfunction contributed significantly to predicting heart risk.
{Journal of the American College of Cardiology, V. 51, No. 10 (11
March 2008), pp. 997-1002}. L-arginine, an amino acid, promotes
healthy blood vessels by its antioxidant properties and reducing
endothelial dysfunction.(a)

Advanced Cardiac Life Sciences, LLC (ACLS), is pleased to announce
the continued success of CardioVance(R) and CardioVance.com, offering
educational resources and evidence-based nutritional supplementation
for women's heart health. CardioVance(R) is cardiologist-formulated
for women concerned about heart health. CardioVance's development
stems from increasing consumer demand to optimize heart health
naturally while at the same time applying scientific rigor to the
development of nutritional supplementation.

CardioVance(R) helps women to improve endothelial dysfunction,
maintain normal blood pressure and cholesterol, and promote a healthy
cardiovascular system by incorporating Omega-3 Fish Oils, CoEnzyme
Q10, L-arginine, Calcium and Vitamin D, and a powerful multivitamin
into a convenient daily nutrition pack.(a)CardioVance.com advances the
fight against women's heart disease, empowers women through
educational resources, and incorporates evidence-based science into
nutritional supplementation.

For additional information or details concerning marketing
CardioVance(R), contact ACLS at 877-490-6787 or visit
www.cardiovance.com. CardioVance is a Registered Trademark of Advanced
Cardiac Life Sciences, LLC. (a)These statements have not been reviewed
by the Food and Drug Administration. This product should be taken as
part of a healthy lifestyle and is not intended to diagnose, treat,
cure, or prevent any disease.

Advanced Cardiac Life Sciences, LLC
Brent Williams, 877-490-6787
Marketing Director
info@cardiovance.com
www.cardiovance.com

Copyright Business Wire 2008